Tag: Cipla

Cipla announces JV with Kemwell Biopharma and Manipal Group for cell therapy development

businessnewstoday- January 8, 2024

Cipla (EU) Limited, UK, a wholly-owned subsidiary of Cipla Limited, has entered into a strategic collaboration with Kemwell Biopharma Private Limited and Manipal Education & ... Read More

Cipla expands digital healthcare reach with further investment in GoApptiv

businessnewstoday- December 16, 2023

Cipla Limited, a leading pharmaceutical company, has announced its decision to further invest approximately INR 42 crore in digital tech company GoApptiv Private Limited. This ... Read More

Cipla’s InvaGen Pharmaceuticals recalls Vigabatrin over seal integrity concerns

businessnewstoday- December 16, 2023

InvaGen Pharmaceuticals Inc., a wholly-owned subsidiary of Cipla Limited, has announced a voluntary recall of one lot of Vigabatrin for Oral Solution, USP 500mg, to ... Read More

Cipla to acquire Actor Pharma to dominate South African OTC market

businessnewstoday- September 4, 2023

In a strategic move that amplifies its commitment to the Over-The-Counter (OTC) business, Cipla South Africa, a 100% owned subsidiary of Cipla Limited (BSE: 500087; ... Read More

Cipla launches Cippoint point-of-care testing device in India

businessnewstoday- January 18, 2023

Indian pharma company Cipla Limited has launched a point-of-care testing device called Cippoint in India for infectious diseases, non-communicable diseases, and other health conditions. The ... Read More

Cipla receives six observations from FDA for Goa manufacturing facility

pallavi123- August 27, 2022

Cipla Ltd said that the US Food and Drug Administration (FDA) has concluded an inspection of the company’s manufacturing facility in Goa and has made ... Read More

Cipla takes stake in renewable energy SPV Clean Max Auriga Power

businessnewstoday- December 15, 2021

Cipla Limited said that it has acquired a stake of up to 33% in Clean Max Auriga Power LLP, a special purpose vehicle (SPV) focused ... Read More

Cipla Limited amends Pulmazole agreement with Pulmatrix

pallavi123- November 9, 2021

Cipla Limited said that its fully-owned step-down subsidiary — Cipla Technologies (CipTec) has completed an amendment to a previously signed agreement with US-based Pulmatrix for ... Read More

Cipla Q2 FY22 profit after tax increases 7% to Rs 665cr

pallavi123- October 26, 2021

Cipla Limited has reported a profit after tax (PAT) of INR 711 crores for the second quarter of the fiscal year 2022 (Q2 FY22), a ... Read More

Cipla signs licensing deal with Lilly to sell two diabetes drugs in India

pallavi123- October 4, 2021

Cipla has signed a licensing deal with the Indian subsidiary of US pharma giant Eli Lilly and Company (Lilly) pertaining to the latter’s diabetes treatments ... Read More